Status:
UNKNOWN
Prevalence of OSA in Patients of ILD
Lead Sponsor:
Assiut University
Conditions:
OSA
Eligibility:
All Genders
18-65 years
Brief Summary
To evaluate the clinical predictors of OSA in patients with ILD
Detailed Description
Interstitial lung diseases (ILDs) are a group of heterogeneous disorders characterized by varying degrees of fibrosis and inflammation of lung parenchyma. Obstructive sleep apnea is a type of sleep d...
Eligibility Criteria
Inclusion
- Patients presented to Chest Department with interstitial lung disease will be included, screened for OSA.
Exclusion
- Age: less than 18 years. Unstable patients or need for ICU admission
Key Trial Info
Start Date :
October 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 25 2024
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT06058052
Start Date
October 20 2023
End Date
December 25 2024
Last Update
September 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.